However, we have identified a role for HMGB3 in resistance to cisplatin, a DNA-damaging chemotherapeutic agent, in human ovarian cancer cells [30], suggesting that HMGB3 might be involved in DNA damage repair. The gene discussed is HMGB3; the disease is ovarian carcinoma.